8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2020 / Phase II double-blind randomized placebo-controlled trial
In a 6-month trial, 44 participants with peripheral artery disease were randomized to consume a daily cocoa beverage (15 g cocoa, 75 mg epicatechin) or a placebo. Adjusting for smoking, race, and BMI, cocoa improved 6-minute walk distance by 42.6 m (90% CI, +22.2 to +∞; P=0.005) at 2.5 hours after a final beverage, and by 18.0 m (90% CI, -1.7 to +∞; P=0.12) at 24 hours post-beverage compared to placebo. Calf muscle biopsies showed cocoa improved mitochondrial cytochrome c oxidase activity (P=0.013), increased capillary density (P=0.014), improved perfusion (P=0.098), and reduced central nuclei (P=0.033).
McDermott MM, Criqui MH, Domanchuk K, et al. Circ Res, 2020. PMID 32078436
2020 / Two-period randomized crossover trial
In a randomized crossover trial, 55 adults with elevated BMI and cardiometabolic risk consumed 3/4 cup/day of mixed dried fruits (plums, figs, dates, raisins) or an isocaloric, carbohydrate-matched control snack for 4 weeks. Lipid and lipoprotein concentrations did not differ between conditions, though dried fruit increased LDL-cholesterol from baseline (0.10 mmol/l, 95% CI 0.01, 0.20). Compared with control, dried fruit increased mean fasting glucose (0.08 mmol/l, 95% CI 0.005, 0.16; P = 0.038), while vascular outcomes, fasting insulin, and C-reactive protein did not differ. Mean weight changes did not differ between groups (P = 0.55), but tended to increase in both.
Sullivan VK, Petersen KS, Kris-Etherton PM Br J Nutr, 2020. PMID 32513313
2020 / Randomized crossover trial
In the SWAP-MEAT crossover trial, 36 healthy adults consumed ≥2 servings/day of plant-based alternative meat versus animal meat for 8 weeks each with no washout period. Overall mean ± SEM TMAO concentrations were lower during the plant phase (2.7 ± 0.3 vs. 4.7 ± 0.9 µM, P = 0.012), though a significant order effect occurred; TMAO was significantly lower only in participants receiving plant meat second. LDL-cholesterol concentrations (109.9 ± 4.5 vs. 120.7 ± 4.5 mg/dL, P = 0.002) and body weight (78.7 ± 3.0 vs. 79.6 ± 3.0 kg, P < 0.001) were also significantly lower during the plant-based phase.
Crimarco A, Springfield S, Petlura C, et al. Am J Clin Nutr, 2020. PMID 32780794
2020 / Parallel-group, double-blind, randomized controlled trial
A parallel-group, double-blind trial randomized 159 patients with CKD stage 3b or 4 to receive 400 μg oral vitamin K2 (n=80) or matching placebo (n=79) once daily for 1 year. The study found no differences between groups in carotid-femoral pulse wave velocity at 12 months, augmentation index at 12 months, blood pressure, B-type natriuretic peptide, or physical function. Furthermore, an updated meta-analysis of trials conducted by the authors showed no effect of vitamin K supplementation on vascular stiffness or vascular calcification measures.
Witham MD, Lees JS, White M, et al. J Am Soc Nephrol, 2020. PMID 32817311
2020 / Double-blind, randomized, multicenter trial
A total of 13,078 statin-treated patients at high cardiovascular risk were randomized to receive 4 g/d of an omega-3 carboxylic acid formulation (EPA/DHA) or corn oil. The trial was prematurely halted for low probability of clinical benefit. The primary composite endpoint occurred in 12.0% of omega-3 CA patients versus 12.2% of corn oil patients (hazard ratio, 0.99 [95% CI, 0.90-1.09]; P = .84). A higher rate of gastrointestinal adverse events occurred in the omega-3 group (24.7%) compared to the corn oil group (14.7%).
Nicholls SJ, Lincoff AM, Garcia M, et al. JAMA, 2020. PMID 33190147
2019 / Double-blind randomized controlled trial
In the double-blinded randomized controlled FLAX-PAD trial, PAD patients consumed a diet supplemented with either 30 g of milled flaxseed or placebo daily for 1 year. At baseline, cardiac arrhythmias were present in 48% of the flaxseed group and 32% of the placebo group. After 1 year, cardiac arrhythmias decreased by 2% in the flaxseed group and increased by 12% in the placebo group, which was not statistically significant (P > 0.05). Electrocardiographic variables did not change in either group, and improvements in initial and absolute claudication distances did not show a statistically significant intergroup difference.
Rodriguez-Leyva D, Rodriguez-Portelles A, Weighell W, et al. Can J Physiol Pharmacol, 2019. PMID 30308127
2019 / Multicenter, randomized, double-blind, placebo-controlled trial
A total of 8179 statin-treated patients with elevated triglycerides were randomized to receive 2 g of icosapent ethyl twice daily (4 g total) or placebo and followed for a median of 4.9 years. The primary composite endpoint occurred in 17.2% of the icosapent ethyl group versus 22.0% of the placebo group (HR, 0.75; 95% CI, 0.68 to 0.83; P<0.001), and cardiovascular death was lower (4.3% vs. 5.2%; HR, 0.80; 95% CI, 0.66 to 0.98; P=0.03). However, hospitalizations for atrial fibrillation or flutter were higher with icosapent ethyl (3.1% vs. 2.1%, P=0.004), and serious bleeding occurred in 2.7% versus 2.1% (P=0.06).
Bhatt DL, Steg PG, Miller M, et al. N Engl J Med, 2019. PMID 30415628
2019 / Randomized, placebo-controlled trial (two-by-two factorial)
A randomized, placebo-controlled trial tested vitamin D3 (2000 IU/day) versus placebo for the prevention of cancer and cardiovascular disease over a median follow-up of 5.3 years in 25,871 participants. Vitamin D was not associated with a lower risk of invasive cancer (HR 0.96; 95% CI, 0.88 to 1.06; P=0.47) or major cardiovascular events (HR 0.97; 95% CI, 0.85 to 1.12; P=0.69). Secondary endpoints, including death from cancer (HR 0.83; 95% CI, 0.67 to 1.02) and death from cardiovascular causes (HR 1.11; 95% CI, 0.88 to 1.40), also showed no significant differences, and no excess risks of hypercalcemia or other adverse events were identified.
Manson JE, Cook NR, Lee IM, et al. N Engl J Med, 2019. PMID 30415629
2019 / Randomized, placebo-controlled, 2x2 factorial trial
In the VITAL trial, 25,871 participants were randomized to 1 g per day of marine n-3 fatty acids or placebo (alongside vitamin D3 in a 2x2 factorial design) with a median follow-up of 5.3 years. Marine n-3 fatty acid supplementation did not significantly lower major cardiovascular events (HR, 0.92; 95% CI, 0.80 to 1.06; P=0.24) or invasive cancer (HR, 1.03; 95% CI, 0.93 to 1.13; P=0.56). For secondary endpoints, total myocardial infarction was lower in the n-3 group (HR, 0.72; 95% CI, 0.59 to 0.90), but stroke, cancer death, and all-cause death showed no significant differences. No excess risks of bleeding or other serious adverse events were observed.
Manson JE, Cook NR, Lee IM, et al. N Engl J Med, 2019. PMID 30415637
2019 / Controlled trial
In a controlled trial, 49 strict vegan participants took oral creatine monohydrate (5 g daily, n = 31) or placebo (n = 18) for three weeks. Creatine intake normalized homocysteine levels in all participants and increased blood folic acid concentrations. Supplementation also increased baseline skin capillary density and endothelium-dependent capillary recruitment, while enhancing microvascular vasodilation specifically in participants with elevated baseline homocysteine.
Van Bavel D, de Moraes R, Tibirica E Fundam Clin Pharmacol, 2019. PMID 30506745
2019 / Clinical trial
Researchers evaluated isotope-labeled l-carnitine and gamma-butyrobetaine metabolism in 40 omnivores and 32 vegans or vegetarians. Following oral d3-l-carnitine, omnivores generated over 20-fold more d3-TMAO than vegans or vegetarians (P = 0.001), despite comparable fasting plasma carnitine levels. Gut bacteria transformed carnitine into gamma-butyrobetaine in both dietary groups, but conversion of gamma-butyrobetaine to TMA was induced by chronic carnitine intake and omnivorous habits.
Koeth RA, Lam-Galvez BR, Kirsop J, et al. J Clin Invest, 2019. PMID 30530985
2019 / Single-blinded randomized controlled trial
In a 12-week single-blinded trial, 77 constipated patients with type 2 diabetes received cookies containing 10 g flaxseed, 10 g psyllium, or placebo twice daily. Compared to placebo, both flaxseed and psyllium groups showed significant improvements from baseline in constipation symptoms (P = 0.002), stool consistency (P < 0.001), weight (P < 0.001), BMI (P < 0.001), fasting plasma glucose (P = 0.004), cholesterol (P = 0.010), LDL cholesterol (P = 0.031), and cholesterol/HDL cholesterol ratio (P = 0.019). Flaxseed appeared superior to psyllium for improving these markers, and no adverse effects were observed.
Soltanian N, Janghorbani M Clin Nutr ESPEN, 2019. PMID 30661699
2019 / Interventional study
Researchers used 16S rRNA gene sequencing to assess the effects of 1 week of chlorhexidine antiseptic mouthwash on tongue bacterial communities and resting systolic blood pressure in healthy, normotensive individuals free of oral disease. Tongue cleaning frequency predicted chlorhexidine-induced changes in blood pressure and microbiome composition. Twice-daily chlorhexidine use was associated with a significant increase in systolic blood pressure after 1 week, and recovery led to enrichment of nitrate-reducing bacteria. Furthermore, participants with relatively high levels of bacterial nitrite reductases demonstrated lower resting systolic blood pressure.
Tribble GD, Angelov N, Weltman R, et al. Front Cell Infect Microbiol, 2019. PMID 30881924
2019 / Cluster randomized controlled trial
A cluster randomized trial evaluated an 8-module workplace wellness program led by dietitians across 160 worksites (20 intervention sites with 4,037 employees and 140 control sites with 28,937 employees). After 18 months, intervention participants reported higher rates of engaging in regular exercise (69.8% vs 61.9%; adjusted difference, 8.3 percentage points) and actively managing weight (69.2% vs 54.7%; adjusted difference, 13.6 percentage points). However, there were no significant effects on 27 other self-reported outcomes (including food choices), 10 clinical markers (including cholesterol, blood pressure, and BMI), 38 health spending/utilization metrics, or 3 employment outcomes.
Song Z, Baicker K JAMA, 2019. PMID 30990549
2019 / Two-phase double-blind randomized clinical trial
A two-phase, double-blind randomized clinical trial evaluated the effects of consuming a flavonoid-rich cocoa beverage daily for up to 12 weeks. In the initial study (60 subjects aged 55-70), the flavonoid-rich group showed improvements in glycemia, triglyceridemia, HDL, LDL, the triglyceridemia/HDL index, oxidative markers, the Up and Go test, skeletal muscle index, and quality of life compared to placebo or non-flavonoid cocoa. In the follow-up study (74 subjects aged 65-90), flavonoid treatment significantly improved metabolic, oxidative stress, and inflammatory endpoints, along with positive effects on physical performance, frailty indicators, and quality of life compared with the non-flavonoid beverage.
Munguia L, Rubio-Gayosso I, Ramirez-Sanchez I, et al. J Gerontol A Biol Sci Med Sci, 2019. PMID 31056655
2019 / Randomized controlled trial
A randomized crossover trial evaluated healthy adults completing diets featuring red meat, white meat, or nonmeat protein for 4 weeks each, nested within high-SFA (n = 61) or low-SFA (n = 52) backgrounds. Both red and white meat raised LDL cholesterol and apolipoprotein B compared with nonmeat protein (P < 0.001), mainly by increasing large LDL particles. Primary lipid outcomes showed no significant differences between red and white meat.
Bergeron N, Chiu S, Williams PT, et al. Am J Clin Nutr, 2019. PMID 31161217
2019 / Randomized controlled trial
The Women's Health Initiative Dietary Modification trial randomized 48,835 postmenopausal women to either a low-fat dietary pattern intervention (reducing fat to 20% of energy and increasing vegetables, fruit, and grains) or a usual-diet comparison group. Time-to-outcome analyses showed no significant differences for invasive breast cancer, colorectal cancer, or coronary heart disease (CHD) over an 8.5-year median intervention or longer-term follow-up. However, over a 19.6-year median follow-up, the intervention group had significantly lower hazards for breast cancer followed by death (HR 0.84; 95% CI: 0.74, 0.96) and diabetes requiring insulin (HR 0.87; 95% CI: 0.77, 0.98), along with other benefits related to breast cancer, CHD, and diabetes without adverse effects.
Prentice RL, Aragaki AK, Howard BV, et al. J Nutr, 2019. PMID 31175807
2019 / Randomized crossover trial
Seventeen healthy young subjects consumed a high-fat meal (HFM) along with water, fruit juice, or champagne in a randomized crossover design. Across the whole group, the HFM caused significant hypertriglyceridemia (from 0.77 ± 0.07 to 1.41 ± 0.18 mmol/L, p < 0.001) without overall impairment of FMD. However, in 10 subjects where HFM decreased FMD (from 10.73 ± 0.95 to 8.1 3± 0.86 and 8.07 ± 1.16%; p < 0.05 and p < 0.01 at 2 and 3 hours, respectively), FMD did not decrease when drinking juice or champagne. The authors concluded that fruit juice or champagne might reduce such alterations, though further studies are needed to determine the mechanisms.
Rouyer O, Auger C, Charles AL, et al. J Clin Med, 2019. PMID 31208093
2019 / Randomized double-blind placebo-controlled trial
In a randomized, double-blind trial, patients with type 2 diabetes and CVD received 360 µg/day menaquinone-7 (MK-7, n=35) or placebo (n=33) for 6 months. Target-to-background ratio (TBR) on 18F-NaF PET scans tended to increase in the MK-7 group compared to placebo (0.25; 95% CI: -0.02, 0.51; P = 0.06), but the change was not significant. Log-transformed CT calcification mass did not significantly differ between groups (0.50; 95% CI: -0.23, 1.36; P = 0.18). MK-7 supplementation significantly decreased dp-ucMGP compared with placebo (-205.6 pmol/L; 95% CI: -255.8, -155.3 pmol/L), and no adverse events occurred.
Zwakenberg SR, de Jong PA, Bartstra JW, et al. Am J Clin Nutr, 2019. PMID 31387121
2019 / Randomized crossover trial
In a randomized crossover study, 24 healthy adult males consumed a high-fat breakfast with or without 50 g of freeze-dried mango pulp. At 1 hour post-meal, mango consumption resulted in significantly lower glucose (95.8 ± 4.4 mg/dL vs. 104.8 ± 5.4 mg/dL; P = .002) and higher HDL-C (58.4 ± 2.7 mg/dL vs. 55.2 ± 2.3 mg/dL; P = .01). However, no significant meal × time interactions were observed for triglycerides (P = .88), inflammatory markers (C-reactive protein, P = .17; interleukin-6, P = .30), or antioxidant enzymes (superoxide dismutase, P = .77; glutathione peroxidase, P = .36; catalase, P = .32).
O'Hara C, Ojo B, Emerson SR, et al. Nutr Metab Insights, 2019. PMID 31452602
2019 / Single-arm pre-post intervention study
Researchers evaluated an 8-week group program utilizing an ad-libitum whole-food plant-based dietary pattern in 79 self-referred participants, with 78 completing. Completers achieved an average weight loss of 5.5 ± 3.0 kg (p < 0.0001), with larger percentage losses in those with higher baseline BMI. Systolic blood pressure decreased by 7.1 ± 15.5 mmHg (p = 0.0002), diastolic blood pressure decreased by 7.3 ± 10.9 mmHg (p < 0.0001), total cholesterol decreased by 25.2 ± 24.7 mg/dL (p < 0.0001), and LDL decreased by 15.3 ± 21.1 mg/dL (p < 0.0001). Additionally, 21 participants (26.9%) decreased or stopped at least one chronic medication.
Campbell EK, Fidahusain M, Campbell Ii TM Nutrients, 2019. PMID 31484341
2019 / Prospective intervention study with a matched control group
Researchers compared 27 overweight/obese women with PCOS to 25 matched controls after a 3-day standardized diet, followed by a 3-month oral contraceptive (OC) intervention with dietary advice in the PCOS group. At baseline, the PCOS group showed significantly higher serum levels of TMAO, choline, betaine, and carnitine, with TMAO and choline correlating with total testosterone. Following the 3-month OC therapy and lifestyle intervention, TMAO and its precursors significantly decreased alongside reductions in BMI, total testosterone, and free androgen index.
Eyupoglu ND, Caliskan Guzelce E, Acikgoz A, et al. Clin Endocrinol (Oxf), 2019. PMID 31556132
2019 / Open-label, randomized counterbalanced crossover trial
Seven healthy older overweight volunteers completed four trials consuming a >900 kcal meal with water (control), orange juice, green tea, or red wine, with at least 3 days between visits. At 2 hours post-meal, triglycerides increased substantially and flow-mediated dilatation (FMD) was significantly reduced by ~35%, accompanied by a reduction in plasma nitrite. Co-ingestion of the antioxidant drinks did not attenuate the reduction in FMD and none of the measured outcomes were influenced by the drinks.
Muggeridge DJ, Goszcz K, Treweeke A, et al. Front Physiol, 2019. PMID 31681007
2018 / Acute postprandial intervention study
Researchers measured acute circulating monocyte responses in venous blood samples from 17 participants before and 1, 3, and 5 hours after consuming a high-fat meal providing 85% of their daily fat allowance. The high-fat meal caused increases in oxidized LDL (oxLDL) uptake, adhesion molecule expression, and CD36 expression in both classical (CD14+/16-) and nonclassical (CD14+/16+) monocytes. Nonclassical monocytes responded with larger increases than classical monocytes.
Henning AL, Venable AS, Vingren JL, et al. Cytometry B Clin Cytom, 2018. PMID 27569052